Document:

ampe_Ex10_1

		
			Exhibit 10.1
		

		
			AMENDMENT TO EMPLOYMENT AGREEMENT
		

		
			This Amendment to Employment Agreement (“Amendment”) is executed on and entered into on August 20, 2019, (the “Effective Date”), by and among Ampio Pharmaceuticals, Inc. (the “Company”), and Daniel Stokely (“Executive”) (collectively, the “Parties”).
		

		
			RECITALS
		

		
			WHEREAS,  the Parties executed an Employment Agreement on July 9, 2019 setting forth certain terms of employment between the Parties; and
		

		
			WHEREAS, the Parties mutually desire to amend the stock option term of compensation set forth in Section 3(b) of the Employment Agreement to bring it into alignment with the requirements the Company’s stock option plan and maximum allowable limits contained therein.
		

		
			NOW, THEREFORE, in consideration of the promises and the mutual covenants and obligations set forth in the Employment Agreement and this Amendment, the Parties hereby agree that Section 3(b) of the Employment Agreement shall be modified as follows:
		

		
			(b)Equity and Long-Term Compensation.  The Company hereby agrees to grant Executive an option to purchase 430,000 400,000 shares of the Company’s common stock (the “Option”) at an exercise price equal to the closing price of the Company’s common stock as reported by the New York Stock Exchange on the Start Date.  The Option shall vest fifty percent (50%) on the Start Date and the remainder three-hundred sixty-five (365) days after the Start Date.  The Option shall be subject to the terms and conditions of the Ampio Pharmaceuticals, Inc. 2010 Stock Option and Incentive Plan, as amended, and a Stock Option Agreement, to be executed.  During the Employment Period, and subject to approval of the Board’s Compensation Committee, Executive shall also be eligible to participate in any equity and/or other long-term compensation programs established by the Company as set forth from time to time for senior executive officers.  Executive’s target annual equity award opportunity shall be determined by the Compensation Committee and shall be no less favorable than the target equity award opportunity available to other similarly-situated senior executives of the Company generally, with the actual award to be determined by the Compensation Committee on a basis not less favorable to Executive than to other similarly-situated senior executives of the Company generally.
		

		
			All remaining terms of the Employment Agreement shall remain in full force and effect, and nothing in this Amendment shall alter any other terms therein in any way.  Enforcement of this Amendment shall be governed by the terms of the Employment Agreement, and this instrument should be treated as an Appendix thereto.
		

		
			[SIGNATURE PAGE TO FOLLOW – REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
		

		
			
		

		
			

		 

		

			Page 1 of 2

		

		

			 

		

		

		
			IN WITNESS WHEREOF, the Company has caused this Amendment to be executed, and Executive has hereunto set Executive’s hand, all as of the Effective Date specified above.
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						Ampio Pharmaceuticals, Inc.

				
	
					
						 

					
					
						By:

					
					
						/s/ Michael Macaluso

				
	
					
						 

					
					
						Name:

					
					
						Michael Macaluso

				
	
					
						 

					
					
						Title:

					
					
						Chief Executive Officer

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						Date:

					
					
						8/20/2019

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						Executive

				
	
					
						 

					
					
						/s/ Daniel Stokely

				
	
					
						 

					
					
						Daniel Stokely

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						Date:

					
					
						8/20/2019

				

		
			 
		

		 

		

			Page 2 of 2ampe_Ex10_2

		
			Exhibit 10.2
		

		
			AMPIO PHARMACEUTICALS, INC.
		

		
			2010 STOCK OPTION AND INCENTIVE PLAN
		

		
			STOCK OPTION CANCELLATION AND GRANT AGREEMENT FOR EXECUTIVE
		

		
			THIS STOCK OPTION CANCELLATION AND GRANT AGREEMENT FOR EXECUTIVE (“Agreement”) is made and entered into as of the 20th day of August, 2019 (“Grant Date”) by and between Ampio Pharmaceuticals, Inc. (the “Company” or “we”) and Daniel Stokely (the “Grantee”);
		

		
			WHEREAS, on July 31, 2019,  Grantee was granted the options shown in Exhibit A which provided the Grantee an option to purchase shares of common stock of the Company under the terms of the Ampio Pharmaceuticals, Inc. 2010 Stock Option and Incentive Plan (the “Plan”) (the “2019 Options”);
		

		
			WHEREAS, the 2019 Options were in violation of Section 3(a) of the Plan that limits grants to 400,000, which makes the 2019 Options invalid;
		

		
			WHEREAS, the Company desires to cancel such 2019 Options and issue new options pursuant to the terms of the Plan; and
		

		
			NOW,  THEREFORE, for and in consideration of the provisions and mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Grantee hereby agree as follows:
		

		
			1.         Surrender of Options.  Grantee hereby agrees that the 2019 Options shall be cancelled.
		

		
			2.         Return of Outstanding Option Documents.  Immediately upon execution of this Agreement, Grantee shall deliver to the Company each “Stock Option Agreement for Executive” between the Company and Grantee.
		

		
			3.         Option Grant.  You are hereby granted the below Option. Your Option permits you to purchase, on the terms and conditions set forth in this Agreement, the number of shares (the “Option Shares”) of the Company’s common stock (the “Common Stock”), at the exercise price (the “Exercise Price”) set forth in the following table.
		

			
					
						 

					
					
						 

				
	
					
						Number of Option Shares

					
					
						Exercise Price Per Option Share

				
	
					
						400,000

					
					
						$0.43

				

		
			 
		

		
			4.         Option Type.  Your Option is not intended to qualify as an incentive stock option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”).
		

		
			5.         Term of Option.  As a general matter, your right to exercise the Option will expire on the tenth anniversary of the Grant Date (the “Expiration Date”).  As provided
		

		
			
		

		
			

		 

		

		
			below, your right to exercise the Option may expire prior to the Expiration Date, if you die or your employment with the Company terminates.
		

		
			6.         Vesting.  You may exercise the Option only to the extent that the Option is vested.  If applicable to you, the Option may vest over time. If so, your right to exercise the Option will vest over time in accordance with the following schedule, provided you are employed with the Company or any of its Subsidiaries (collectively, the “Ampio Companies”) on the applicable date listed below.
		

			
					
						Date

					
					
						Vested Percentage of Award

				
	
					
						Grant Date

					
					
						50%

				
	
					
						July 31, 2022

					
					
						50%

				

		
			 
		

		
			Your Option may also be subject to performance vesting criteria.  If so, the terms under which your Option will vest are set forth in a schedule attached hereto and incorporated by reference into this Award. To the extent performance vesting criteria apply to your Award, the determination of whether subjective performance vesting criteria have been met is in the sole discretion of the Compensation Committee of the Company’s Board of Directors (the “Committee”).  The attaining of the objective performance criteria shall be determined in accordance with the terms of the attached schedule.  If the attaining of objective performance criteria is subject to interpretation, you and we agree that any judgment as to whether the objective performance criteria have been met shall be in the sole, but reasonably exercised, discretion of the Committee.
		

		
			Except as otherwise provided in Section 9 below, if your employment with the Ampio Companies terminates you will forfeit that portion of the Award that is not vested on the date of your termination.
		

		
			7.         Sale Event Vesting.  In the event that a Sale Event occurs with respect to the Company, any portion of your Option that is not vested shall vest, and become exercisable, upon such Sale Event.
		

		
			8.         Exercise.  Prior to the Expiration Date and during your employment with the Ampio Companies, you may exercise all or a portion of your Option, to the extent vested, by designation the number of Option Shares to be acquired in accordance with the exercise procedures established by the Committee from time to time.  Your right to exercise the Option, to the extent vested, following the date your employment terminates will depend on the reason for such termination, as described in Section 9 below.
		

		
			You must pay to the Company at the time of exercise the sum of (i) the full amount of the Exercise Price for the number of Option Shares to be acquired and (ii) an amount equal to the aggregate minimum federal, state and local income and employment taxes that the Company is required to withhold and deposit on behalf of you with respect to your exercise (“Tax Obligation”).
		

		
			
		

		
			

		 

		

			-2-

		

		

		
			You may elect to pay the Exercise Price or your Tax Obligation by having the Company reduce the number of Option Shares you receive upon such exercise.  Alternatively, you may pay the Exercise Price and your Tax Obligation:
		

		
			a.         in cash;
		

		
			b.         by surrendering to the Company previously acquired shares of Common Stock having a Fair Market Value at the time of exercise equal to the Exercise Price or Tax Obligation; or
		

		
			c.         to the extent permitted by applicable law, by delivery of irrevocable instructions to a broker to (1) promptly deliver to the Company the amount of sale proceeds from the Option Shares or other proceeds to pay the Exercise Price or the Tax Obligation, and (2) deliver to you the balance of the Option Share proceeds in the form of cash or shares of Common Stock.
		

		
			If you pay the Exercise Price or your Tax Obligation by surrender of shares of Common Stock, you must also submit proof acceptable to the Company substantiating your ownership of those shares.  The value of previously acquired shares of Common Stock used to pay the Exercise Price (either directly or by attestation) of the Option Shares to be acquired or your Tax Obligation shall be equal to the aggregate Fair Market Value of such previously acquired shares of Common Stock on the date of the exercise.  Your Option will be considered finally exercised on the date on which your payment of the Exercise Price and Tax Obligation is received by the Company.  By exercising any portion of the Option, you are accepting all of the terms and conditions specified in this Agreement.
		

		
			9.         Impact of Termination of Employment on Option.  Except as otherwise expressly provided in this Section 9 or otherwise agreed to by the Committee, if you are an employee and your employment with the Ampio Companies terminates, (i) you will forfeit that portion of your Option that is not vested on the date of your termination and (ii) you will have a limited period in which to exercise such portion of any Option as was vested on the date of your termination.  The Committee, in its sole discretion, shall be authorized to determine the nature of any termination of employment and your rights under this Section 9 as a result of such termination and such determination shall be binding for all purposes under this Section 9.
		

		
			a.         Death or Disability.  If you die or if the Company elects to terminate your employment with the Ampio Companies due to your Disability, (i) your Option to the extent not previously vested will vest and become non-forfeitable as of the date of your death or the date your employment terminates due to your Disability and (ii) your Option may be exercised thereafter at any time that is both before the Expiration Date and within one year of the date of your death or termination.  To the extent not previously exercised, your Option will terminate and may not be exercised after the earlier of the Expiration Date or the first anniversary of the termination of your employment due to your death or your permanent Disability.
		

		
			
		

		
			

		 

		

			-3-

		

		

		
			Your employment will be considered to have been terminated due to your Disability if the Committee determines, in its sole discretion, that at the time your employment terminates you were unable to perform any material portion of your assigned duties and responsibilities, with or without accommodation, due to a mental or physical condition that is expected to last indefinitely.  In making this determination, the Committee may rely upon such information as it deems necessary or appropriate.
		

		
			b.         Voluntary Termination other than for Good Reason.  If you voluntarily terminate your employment with the Ampio Companies other than for Good Reason, (i) your Option to the extent not previously vested will terminate and be forfeited as of the date your employment terminates, and (ii) your Option, to the extent vested, may be exercised during the 90-day period immediately following the date your employment terminates.  Any vested portion of the Option which remains unexercised will be forfeited, and your right to exercise that portion of the Option shall terminate, on the 91st day following the date your employment terminates.  For purposes of this Award, “Good Reason” shall have the meaning set forth in the employment agreement between you and any of the Ampio Companies.  In the event that you are not party to an employment agreement or your employment agreement does not contain a definition of “Good Reason,” it shall mean, without your written consent: (i) there is a material reduction of the level of your compensation (except where there is a general reduction also applicable to the other members of the senior executive team), or (ii) there is a material reduction in your overall responsibilities or authority, or scope of duties (it being understood that the occurrence of a change in control shall not, by itself, necessarily constitute a reduction in your responsibilities or authority).  No event shall be deemed to be “Good Reason” if the Company has cured the event (if susceptible to cure) within thirty (30) days of receipt of written notice from you specifying the event or events that, absent cure, would constitute “Good Reason.”
		

		
			c.         Voluntary Termination for Good Reason.  If you voluntarily terminate your employment with the Ampio Companies for Good Reason, (i) any portion of your Option that is not vested shall vest, and become exercisable, upon the date your employment terminates, and (ii) your Option may be exercised during the one-year period immediately following the date your employment terminates or until the Expiration Date, if earlier. Any vested portion of the Option which remains unexercised will be forfeited, and your right to exercise that portion of the Option shall terminate, on the earlier of the Expiration Date or the first day following the one-year anniversary of the date your employment terminates.
		

		
			d.         Involuntary Termination.  If your employment with Ampio Companies is terminated by the Company other than for Cause, (i) any portion of your Option that is not vested shall vest, and become exercisable, upon the date your employment terminates, and (ii) your Option may be exercised during
		

		
			
		

		
			

		 

		

			-4-

		

		

		
			the one-year period immediately following the date your employment terminates or until the Expiration Date, if earlier. Any vested portion of the Option which remains unexercised will be forfeited, and your right to exercise that portion of the Option shall terminate, on the earlier of the Expiration Date or the first day following the one-year anniversary of the date your employment terminates.  For purposes of this Award, “Cause” shall have the meaning set forth in the employment agreement between you and any of the Ampio Companies.  In the event that you are not party to an employment agreement or your employment agreement does not contain a definition of “Cause,” it shall mean your failure or refusal to substantially perform your duties hereunder; personal or professional dishonesty that could reasonably be expected to have a materially adverse impact on the financial interests or business reputation of the Company; incompetence; willful misconduct; breach of fiduciary duty (including duties involving personal profit); breach of the Company’s code of ethics; breach of the Company’s codes of conduct and personnel policies; breach of the Company’s compliance policies; material violation of the Sarbanes-Oxley requirements for officers of public companies that in the reasonable opinion of the Board will likely cause substantial financial harm or substantial injury to the reputation of the Company; willfully engaging in actions that in the reasonable opinion of the Board will likely cause substantial financial harm or substantial injury to the business reputation of the Company; willful violation of any law, rule, or regulation, or final cease-and-desist order (other than routine traffic violations or similar offenses); the unauthorized use or disclosure of any trade secret, proprietary, or confidential information of the Company (or any other party as to which you owe an obligation of nondisclosure as a result of your relationship with the Company), including Trade Secret and Confidential Information (as defined the employment agreement between you and the Company);  failure to follow the reasonable and lawful directives of the CEO or the Board pertaining to your duties with the Company; commission of an act of fraud, embezzlement, or misappropriation by you with respect to your relations with the Company or any of its employees, customers, agents, or representatives; or any material breach of any provision of this Agreement.  For purposes hereof, no act or failure to act, on the part of you, shall be considered “willful” unless it is done, or omitted to be done, by you in bad faith or without an objectively reasonable belief that your action or omission was in the best interests of the Company.  Any act or failure to act, whether based upon the direction of the Board or based upon the advice of counsel for the Company, shall be conclusively presumed to be done, or omitted to be done, by you in good faith and in the best interests of the Company.
		

		
			 
		

		
			
		

		
			

		 

		

			-5-

		

		

		
			e.         Termination for Cause.  If your employment with the Ampio Companies is terminated for Cause, your Option will be forfeited and your rights to exercise the Option, whether or not vested, shall terminate as of the date your employment terminates.
		

		
			10.       Adjustments In Capitalization.  In the event of any dividend or other distribution (in whatever form), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company, issuance of warrants or other rights to purchase Common Stock or other securities of the Company, or other similar transaction or event that affects the Common Stock, the Committee shall adjust the terms of the Option, to the extent necessary, in its sole discretion, in order to prevent dilution or enlargement of the benefits or potential benefits of the Option.  However, in no event shall the Committee adjust the terms of the Option in a manner which could cause the Option to be treated as the grant of a new Option for purposes of Section 409A of the Code and Treas. Reg. §§ 1.409A-2 through 1.409A-6 or cause the Company to incur a new compensation charge for financial reporting purposes.
		

		
			11.       Rights as a Stockholder.  You will have no rights as a stockholder with respect to any Option Shares until and unless you exercise the Option and shares of Common Stock have been issued to you.
		

		
			12.       Public Offer Waiver.  By executing this Agreement, you acknowledge and confirm your understanding that your rights under the Plan arise strictly from your status as an employee of or service provider to the Ampio Companies and that the Company’s grant of the Option to you is not an offer of securities made to the general public.
		

		
			13.       Transferability of Option Shares.  You hereby agree not to offer, sell or otherwise attempt to dispose of any Common Stock covered by the Option Shares in a way which would: (i) require the Company to file any registration statement with the Securities and Exchange Commission (or any similar filing under state law or the laws of any other country) or to amend or supplement any such filing, or (ii) violate or cause the Company to violate the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, any other state or federal law, or the laws of any other country.  The Company reserves the right to place restrictions on any Common Stock you may receive as a result of your exercise of the Option.
		

		
			14.       Conformity with the Plan.  This Option is intended to conform in all respects with, and is subject to, all applicable provisions of the Plan. Inconsistencies between this Agreement and the Plan shall be resolved in accordance with the terms of the Plan. By accepting your Option, you agree to be bound by the terms and conditions of this Agreement, the Plan, and any and all conditions established by the Company in connection with Options issued under the Plan. You also understand that this Agreement does not give you any legal or equitable right (other than those rights
		

		
			
		

		
			

		 

		

			-6-

		

		

		
			constituting the Agreement itself) against the Ampio Companies directly or indirectly or give rise to any cause of action at law or in equity against the Ampio Companies.
		

		
			15.       Interpretations.  Any dispute, disagreement or question which arises under, or as a result of, or in any way relates to the interpretation, construction or application of terms of this Agreement or the Plan will be determined and resolved by the Committee or its authorized delegate. The Committee’s determination or resolution will be final, binding and conclusive for all purposes.
		

		
			16.       No Rights to Continued Employment or Future Awards.  You hereby acknowledge and understand that this Option shall not form part of any contract of employment between you and any of the Ampio Companies.  Nothing in the Agreement or the Plan confers on you any right to continue in the employ of the Ampio Companies or in any way affects the Ampio Companies’ right to terminate your employment without prior notice at any time or for any reason, whether you have an employment agreement or whether you are an “at-will” employee. You further acknowledge that the Option is being granted to you in consideration of your performance of services for the Ampio Companies and is not under any circumstances to be considered compensation for past services.
		

		
			You acknowledge and agree that the granting of your Option is at the discretion of the Committee and that acceptance of your Option is no guarantee that future Options will be granted under the Plan.  Notwithstanding anything in this Agreement or the Plan to the contrary, the Company may amend this Agreement or the Plan, including but not limited to modifications to any of the rights granted to you under this Agreement, without your consent, at such lime and in such manner as the Company may consider necessary or desirable, to reflect changes in law. You also understand that the Company may amend, resubmit, alter, change, suspend, cancel, or discontinue the Plan at any time without limitation.
		

		
			17.       Consent to Transfer Personal Data.  You hereby acknowledge and consent to the collection, use, processing and transfer of your personal data as described in this Section 17.  You are not obligated to consent to such a collection, use, processing and transfer of personal data.  However, failure to provide your consent may affect your ability to participate in the Plan.  As part of your employment with the Ampio Companies, the Company may maintain certain personal information about you, that may include your name, home address and telephone number, fax number, email address, family size, marital status, sex, beneficiary information, emergency contacts, passport/visa information, age, language skills, driver’s license information, date of birth, birth certificate, social security number or other employee identification number, nationality, C.V. (or resume), wage history, employment references, job title, employment or severance contract, current wage and benefits information, personal bank account number, tax related information, plan or benefit enrollment forms and elections, options or benefit statements, any shares of stock or directorships in the Company, and details of all options or any other entitlements to shares of stock awarded, canceled, purchased, vested,
		

		
			
		

		
			

		 

		

			-7-

		

		

		
			unvested or outstanding in your favor (the “Data”).  The Company maintains the Data for the purpose of managing and administering the Plan. The Ampio Companies may transfer Data amongst themselves as needed to implement, administer and manage your participation in the Plan, and the Company may also transfer Data to third parties assisting the Company in the implementation, administration and management of the Plan.  These third parties may be located throughout the world, including within the United States.  By voluntarily acknowledging receipt of the Option Shares, you are authorizing these third parties to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any transfer of the Data that may be required to administer the Plan and/or to permit a broker, or other third party you have chosen to hold any shares of Company Common Stock you may acquire pursuant to the Plan.  You may, at any time, review the Data, require any necessary amendments to it or withdraw your consent to its collection by contacting the Company in writing; however, withdrawing your consent may affect your ability to participate in the Plan.
		

		
			18.       Miscellaneous.
		

		
			a.         Modification. The Committee (or its authorized delegate) shall make all determinations regarding the number of Option Shares granted to you and the conditions set forth in this Agreement.  The Committee shall maintain a copy of your Agreement in its records.  The Committee may amend or modify this Agreement in any manner, provided that the Committee would have had the authority to do so under the Plan.  However, no amendment or modification of this Agreement shall impair your rights under this Agreement without your express consent. Any such amendment, modification or supplementation of this Agreement must be in writing and signed by both you and a representative of the Company.
		

		
			b.         Governing Law.  This Agreement and the Plan shall be construed in accordance with the laws of the State of Delaware, without reference to any conflict of law principals.
		

		
			c.         Successors and Assigns.  Except as otherwise provided herein, this Agreement will bind and inure to the benefit of the respective successors and permitted assigns of you and the Company, whether so expressed or not.
		

		
			d.        Waiver.  The failure of the Company to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or any other provision hereof.
		

		
			e.         Severability.  Whenever feasible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or
		

		
			
		

		
			

		 

		

			-8-

		

		

		
			invalid under applicable law, such provision will be ineffective only to the extent of such prohibition or invalidity, without invaliding the remainder of this Agreement.
		

		
			f.          Terms. Initially capitalized terms used in this Agreement and defined in the Plan shall have the meanings given to such terms in the Plan. Copies of the Plan are available upon request to the Company.
		

		
			IN WITNESS WHEREOF, the undersigned have executed this Agreement effective as of the day and year first above written, which constitutes the date upon which the Committee authorized the issuance of the Option.
		

			
					
						 

					
					
						Company:

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						AMPIO PHARMACEUTICALS, INC.

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						By:

					
					
						/s/ Michael Macaluso

				
	
					
						 

					
					
						 

					
					
						Michael Macaluso, Chief Executive Officer

				
	
					
						 

					
					
						 

					
					
						 

				

		
			 
		

			
					
						 

					
					
						 

				
	
					
						 

					
					
						Grantee:

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						/s/ Daniel Stokely

				
	
					
						 

					
					
						Daniel Stokely

				

		
			 
		

		
			 
		

		
			
		

		
			

		 

		

			-9-

		

		

		
			Exhibit A
		

		
			Options Previously Granted
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						Grant Date

					
					
						Number of Options

					
					
						Number of Vested Outstanding Options

				
	
					
						July 31, 2019

					
					
						430,000

					
					
						215,000

				

		
			 
		

		 

		

			-10-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]